iCAD Appoints Andrew Sassine to Board of Directors
Researchers to Present Updated Data Regarding Intraoperative Radiation Therapy with the Xoft System at San Antonio Breast Cancer Symposium
iCAD Featuring New Technology for Automated Breast Density Assessment and Showcasing Solutions for Tomosynthesis at RSNA 2015
iCAD Reports Use Of Xoft® Axxent® Electronic Brachytherapy System In The Treatment Of More Than 15,000 Non-Melanoma Skin Cancer Lesions
iCAD to Present at the LD Micro "Main Event" Microcap Conference
iCAD’s Xoft System Selected as a Popular Science Magazine “Best of What’s New” Award Winner
iCAD to Present at the Drexel Hamilton Micro Cap Investor Forum
iCAD Reports Third Quarter 2015 Financial Results
Researchers to Present Up to 5-Year Positive Clinical Data Supporting
Use of Xoft System for Early-Stage Breast Cancer and Nonmelanoma Skin Cancer at ASTRO 2015
iCAD to Host Third Quarter 2015 Financial Results Conference Call on Thursday, October 29, 2015
iCAD Launches National Educational Program to Increase Awareness of the Effective Use of Electronic Brachytherapy for the Treatment of Nonmelanoma Skin Cancer
iCAD to Present at the 6th Annual Craig-Hallum Apha Select Conference
iCAD Announces Appointment of Two Vice Presidents to Lead Cancer Detection Sales and Marketing Teams
iCAD to Present at Sidoti Emerging Growth Conference
iCAD Reports Second Quarter 2015 Financial Results
iCAD to Host Second Quarter 2015 Financial Results Conference Call on Wednesday, August 5, 2015
ICAD ANNOUNCES COMMERCIAL AVAILABILITY OF CERVICAL APPLICATOR FOR TREATMENT OF GYNECOLOGICAL CANCERS AT AMERICAN ASSOCIATION OF PHYSICISTS IN MEDICINE MEETING
iCAD Announces Launch of iReveal® Breast Density Analysis Solution as Latest Addition to PowerLook Advanced Mammography Platform
iCAD to Present at The 5th Annual LD Micro Invitational
iCAD, Inc. Withdraws 2015 Financial Guidance Due to General Reimbursement Uncertainty
iCAD, Inc. Announces Information Related To Reimbursement Levels.
iCAD Launches Digital Customer Training Platform to Support Professional Education in Use of Xoft System for Treatment of Non-Melanoma Skin Cancer, Early-Stage Breast Cancer and Gynecological Cancers.
iCAD Reports First Quarter 2015 Financial Results.
iCAD Acquires Breast Density Software to Expand Portfolio of Advanced Technologies in Support of Breast Cancer Detection.
First Hospital in Spain Adopts Xoft Electronic Brachytherapy System for the Treatment of Early-stage Breast Cancer, Non-melanoma Skin Cancer and Gynecological Cancers.
iCAD to Host First Quarter 2015 Financial Results Conference Call on Thursday, April 30, 2015.
POSITIVE CLINICAL DATA FOR iCAD’S XOFT SYSTEM TO BE HIGHLIGHTED AT AMERICAN BRACHYTHERAPY SOCIETY (ABS) ANNUAL MEETING.
iCAD to Present Positive Four-year Data on Xoft® Axxent® Electronic Brachytherapy (eBx®) System® for Non-melanoma Skin Cancer (NMSC).
iCAD to Present at the 27th Annual Roth Conference on Wednesday March 11, 2015.
iCAD Reports Fourth Quarter and Fiscal Year 2014 Financial Results.
iCAD to Host Fourth Quarter and Full Year 2014 Financial Results Conference Call on Tuesday, February 24, 2015.
Berry & Company
Public Relations, LLC
iCAD delivers innovative cancer detection and radiation therapy solutions and services that enable clinicians to find and treat cancers earlier and while enhancing patient care. iCAD offers a comprehensive range of upgradeable computer aided detection (CAD) and workflow solutions to support rapid and accurate detection of breast, prostate and colorectal cancers.
© 2017, iCAD Inc. All rights reserved. iCAD, the iCAD logo and Never Stop Looking is a trademark of iCAD, Inc.
Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.